title: Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.
abstract: The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor-node-metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan-Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial-mesenchymal transition in gastric cancer.
authors.affiliation: Department of General Surgery, Xiangya Hospital, Central South University, Xiangya Road, Changsha, 410008, Hunan, People's Republic of China.
authors.forename: Futao
authors.initials: F
authors.lastname: Hou
authors.forename: Weijie
authors.initials: W
authors.lastname: Yuan
authors.forename: Jin
authors.initials: J
authors.lastname: Huang
authors.forename: Liyuan
authors.initials: L
authors.lastname: Qian
authors.forename: Zhikang
authors.initials: Z
authors.lastname: Chen
authors.forename: Jie
authors.initials: J
authors.lastname: Ge
authors.forename: Shaobin
authors.initials: S
authors.lastname: Wu
authors.forename: Jinxiang
authors.initials: J
authors.lastname: Chen
authors.forename: Jixu
authors.initials: J
authors.lastname: Wang
authors.forename: Zihua
authors.initials: Z
authors.lastname: Chen
mesh_terms: D000328:Adult; D000368:Aged; D015820:Cadherins / Q000032:analysis; D058750:Epithelial-Mesenchymal Transition; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D036104:Receptor, EphA2 / Q000032:analysis / Q000502:physiology*; D013274:Stomach Neoplasms / Q000737:chemistry / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D014746:Vimentin / Q000032:analysis; D051176:beta Catenin / Q000032:analysis
chemical_list: C495270:CTNNB1 protein, human; D015820:Cadherins; D014746:Vimentin; D051176:beta Catenin; D036104:Receptor, EphA2